Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Fenbendazole clears hookworms in dogs, cats and livestock with decades of veterinary evidence behind it — but it is not an approved or studied treatment for human hookworm infection.
Fenbendazole has real veterinary evidence behind it for treating Giardia in dogs and cats, but no clinical evidence supports its use for giardiasis in humans.
Fenbendazole is a veterinary dewormer, not an approved human drug, so formal interaction data are limited. Here is what the pharmacology actually tells us.
Fenbendazole is a veterinary dewormer, not an approved human drug. Here is what toxicology, veterinary data, and human case reports actually show about its risks.
Fenbendazole and mebendazole share a drug class and mechanism, but one is a veterinary medicine and the other a licensed human drug—an important distinction.
Fenbendazole is a well-studied veterinary dewormer with strong animal evidence but no FDA approval for human use.
Fenbendazole belongs to a drug class that disables a cell's internal scaffolding. Here is what the tubulin research actually shows—and does not show.
A sober look at fenbendazole's laboratory and animal cancer studies — what has been shown, what hasn't, and what remains unknown in humans.
In 2016, Joe Tippens was given three months to live with small-cell lung cancer. His recovery with fenbendazole sparked a global research movement.